摘要
目的:探讨Sysmex-CA7000和BE-Compact凝血分析仪检测结果的可比性。方法:收集60例新鲜血浆标本,采用两种凝血分析仪测定凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)和纤维蛋白原(FBG),并比对结果,以医学决定水平的系统误差来判断检测系统结果是否为临床接受。结果:Sysmex-CA7000和BE-Compact凝血分析仪检测所得的PT、APTT、Fbg结果比较,差异均有统计学意义(P<0.05),相关系数分别为0.991、0.990、0.981;医学决定水平的系统误差大部分小于总允许误差的1/2。结论:以BE-Compact作为标准检测系统,Sysmex-CA7000的测定结果具有临床可接受性;应定期对同一实验室不同凝血分析仪进行比对实验,以保证检验结果可比性。
Objective ：To investigate the comparability of test results between different coagulation analyzers of CA-7000 and BE-Compact. Methods： 60 cases of fresh plasma samples were collected and detected their prothrombin time （PT）, activated partial thromboplastin time （AVVF） and fibfinogen （FBG） using the two coagulation analyzers. The test results were then compared and decided as to whether the results of different systems were accepted in clinic using the systemic error at medical determining level. Results： There was significant difference in PT, APTr and FBG results detected by detected by coagulation analyzers of Sysmex- CA7000 and BE-Compact （P 〈0.05） , and the related coefficients were 0. 991, 0. 990 and 0. 981. Most of the systemic errors were less than half of the total error allowance. Conclusion： The result of Sysmex-CA7000 was acceptable in clinic as compared with that of BE-Compact as the standard detective system. The different coagulation analyzers in the same laboratory should be periodically used to performed comparison trials in order to guarantee the comparability of test results.
出处
《广州医学院学报》
2012年第5期25-27,共3页
Academic Journal of Guangzhou Medical College
作者简介
汤旭东（1978-），男，硕士，检验师。研究方向：止血与血栓。通讯作者：E-mail：dfx811@126．com。
